Brief: Sinomab Bioscience Agreed To Allot & Issue 28.7 Mln Subscription Shares
02/11/2022 13:14
Nov 2 (Reuters) - SinoMab BioScience Ltd 3681.HK :
* CO AGREED TO ALLOT AND ISSUE 28.7 MILLION SUBSCRIPTION
SHARES
FOR HK$1.78 PER SHARE
Further company coverage: 3681.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinomab Bioscience
See all newsBrief: Sinomab Bioscience Posts HY Loss Of RMB127.4 Million
Brief: Sinomab Bioscience Says Fang Liang Resigns As Executive Director
Brief: Sinomab Bioscience Announces Major Deal For Disposal Of Suzhou Property And Facility For RMB280 MLN
Brief: SinoMab Bioscience Appoints Fang Liang As Executive Director
Brief: Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience